Home/Filings/4/0001209191-21-039224
4//SEC Filing

Cox Russell J. 4

Accession 0001209191-21-039224

CIK 0001636282other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:23 PM ET

Size

5.5 KB

Accession

0001209191-21-039224

Insider Transaction Report

Form 4
Period: 2021-06-08
Transactions
  • Award

    Director Stock Option (right to buy)

    2021-06-08+40,00040,000 total
    Exercise: $6.80Exp: 2031-06-07Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0001512984

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:23 PM ET
Size
5.5 KB